Tengjun Biotechnology Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 51.29 million. Net loss was USD 3.26 million compared to USD 0.222081 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.01 a year ago.
For the six months, sales was USD 55.57 million. Net loss was USD 3.04 million compared to USD 0.38818 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.02 a year ago.